Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medications for lung cancer proliferation and metastasis

Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medications for lung cancer proliferation and metastasis

US Patent 10959977 · Granted Mar 30, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of genetically engineered strain VNP20009-M in preventing and treating cance2025
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Method for synthesizing tetrahydroisoquinoline thiazolidine2019
Capacitive control element with improved malfunction immunity2019